Variantyx
PrivateLast Round
VC Round
Apr 26, 2024
Total Funding Raised
$94.5M
Company Overview
Variantyx is a biotechnology company that provides whole genome sequencing and analysis services for diagnosing rare inherited disorders, reproductive health, and precision oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Variantyx Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Variantyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 26, 2024 | ||||
| Series C | Oct 18, 2023 | ||||
| Debt | Oct 18, 2022 | ||||
| Series C Extension | Feb 14, 2022 | ||||
| Series C | Mar 15, 2021 | ||||
Series B | Jun 6, 2019 |
Variantyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Debt |
| Bosch Ventures | VC Round, Series C, Series C Extension |
| New Era Capital Partners | VC Round, Series C, Series B, Series C Extension |
| Peregrine Ventures (California) | VC Round |
| Kreos Capital | Debt |
| IBM Ventures | Series C |
| GF Financial Markets (UK) Limited | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2025
Launched proprietary Genomic Unity® testing platform for whole genome sequencing diagnostics.
- Oct 14, 2025
Company is a CLIA/CAP-certified genomics company.
Variantyx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Variantyx's valuation, stock price, and market status.